Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

OBIO

Orchestra BioMed Holdings Inc

Dec 20 • 04:00PM ET

4.92

Dollar change +0.12
Percentage change 2.50	%

Healthcare • Biotechnology • USA • NASD

Peers: BSX ABT MDT JNJ STXS SYK IART STE GMED PEN

| Held by: VTI IWM VXF IWN SCHA VTWO IWO IWC SCHB RSSL

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.59	Insider Own	30.48%	Shs Outstand	37.94M	Perf Week	-6.46%
Market Cap	191.71M	Forward P/E	-	EPS next Y	-1.95	Insider Trans	-0.17%	Shs Float	26.43M	Perf Month	-6.82%
Income	-57.69M	PEG	-	EPS next Q	-0.43	Inst Own	49.53%	Short Float	2.91%	Perf Quarter	2.29%
Sales	2.65M	P/S	72.34	EPS this Y	-12.07%	Inst Trans	146.35%	Short Ratio	13.70	Perf Half Y	-28.59%
Book/sh	1.22	P/B	4.04	EPS next Y	-17.76%	ROA	-60.19%	Short Interest	0.77M	Perf Year	-49.80%
Cash/sh	1.72	P/C	2.86	EPS next 5Y	-	ROE	-91.66%	52W Range	4.22 - 10.44	Perf YTD	-46.11%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-121.03%	52W High	-52.87%	Beta	0.48
Dividend TTM	-	Quick Ratio	4.21	Sales past 5Y	-7.29%	Gross Margin	82.89%	52W Low	16.59%	ATR (14)	0.47
Dividend Ex-Date	-	Current Ratio	4.23	EPS Y/Y TTM	-32.61%	Oper. Margin	-2270.68%	RSI (14)	41.70	Volatility	10.72% 8.96%
Employees	56	Debt/Eq	0.04	Sales Y/Y TTM	5.96%	Profit Margin	-2179.34%	Recom	1.00	Target Price	15.60
Option/Short	No / Yes	LT Debt/Eq	0.03	EPS Q/Q	-8.52%	Payout	-	Rel Volume	3.40	Prev Close	4.80
Sales Surprise	40.34%	EPS Surprise	4.65%	Sales Q/Q	135.56%	Earnings	Nov 12 AMC	Avg Volume	56.19K	Price	4.92
SMA20	-7.75%	SMA50	-11.31%	SMA200	-16.66%	Trades		Volume	191,268	Change	2.50%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-22-24	Initiated	H.C. Wainwright	Buy	$14
Jul-25-24	Initiated	B. Riley Securities	Buy	$15
Jan-19-24	Initiated	Jefferies	Buy	$14
Feb-24-23	Initiated	Piper Sandler	Overweight	$15
Feb-07-23	Initiated	Chardan Capital Markets	Buy	$20

Dec-09-24 07:00AM	Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting (GlobeNewswire) +9.54%
Nov-26-24 04:05PM	Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-12-24 06:05PM	Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.67% +7.24%
04:12PM	Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire)
Nov-07-24 08:00AM	Orchestra BioMed to Participate in Jefferies London Healthcare Conference (GlobeNewswire) -5.50%
05:35PM	Loading…
Aug-12-24 05:35PM	Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:20PM	Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire)
Aug-08-24 09:35AM	Orchestra BioMed Holdings, Inc. (OBIO) Loses -25.35% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +13.55%
Aug-01-24 10:01AM	Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) -7.18%
Jul-30-24 08:00AM	Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors (GlobeNewswire)
Jul-26-24 12:00PM	Orchestra BioMed Holdings, Inc. (OBIO) Upgraded to Buy: Here's What You Should Know (Zacks) -6.70%
09:55AM	Wall Street Analysts Believe Orchestra BioMed Holdings, Inc. (OBIO) Could Rally 102.61%: Here's is How to Trade (Zacks)
Jul-23-24 09:00AM	Precision Neuroscience Expands Executive Team as Brain Computer Interface Industry Rapidly Advances (GlobeNewswire)
Jun-24-24 08:07AM	Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar? (Zacks) +9.02%
Jun-04-24 08:00AM	Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 (GlobeNewswire) +10.64%
12:00PM	Loading…
Jun-03-24 12:00PM	All You Need to Know About Orchestra BioMed Holdings, Inc. (OBIO) Rating Upgrade to Buy (Zacks)
09:55AM	Does Orchestra BioMed Holdings, Inc. (OBIO) Have the Potential to Rally 135.64% as Wall Street Analysts Expect? (Zacks)
May-22-24 08:43AM	Orchestra BioMed to Participate in Jefferies Global Healthcare Conference (GlobeNewswire)
May-13-24 09:53PM	OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) +13.04%
06:05PM	Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:58PM	Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire)
Apr-30-24 08:30AM	Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents (GlobeNewswire)
08:00AM	Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 (GlobeNewswire)
Mar-27-24 04:17PM	Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update (GlobeNewswire)
Mar-26-24 08:00AM	Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors (GlobeNewswire) +5.20%
Mar-13-24 08:00AM	Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting (GlobeNewswire)
Mar-07-24 08:00AM	Orchestra BioMed to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.62%
Mar-06-24 08:37AM	Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients (GlobeNewswire)
Feb-26-24 08:00AM	Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years (GlobeNewswire)
Feb-16-24 09:13AM	Why Orchestra BioMed (OBIO) Might Surprise This Earnings Season (Zacks) -8.45%
07:30AM	Loading…
Jan-08-24 07:30AM	Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients (GlobeNewswire) +9.38%
Nov-13-23 04:21PM	Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +14.61% +13.08%
Nov-09-23 04:42PM	Orchestra BioMed to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-30-23 03:52PM	Billionaire Marc Lasrys Top 10 Stock Picks (Insider Monkey)
Sep-22-23 11:27AM	Lab Notes: Main Line firm spins off company that will focus on OTC product pipeline (American City Business Journals)
Sep-19-23 02:37PM	Rebel's Edge - September 19: $NIO, $BHC, $OBIO, and the Firing of MSU's Football Coach (TheStreet.com) +27.61%
07:30AM	Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients (GlobeNewswire)
Sep-06-23 05:00PM	Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors (GlobeNewswire) -7.74%
Aug-10-23 04:34PM	Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +7.05%
Aug-08-23 08:30AM	Orchestra BioMed Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon in Patients with Coronary In-Stent Restenosis (GlobeNewswire)
Jul-27-23 09:47AM	Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) stock most popular amongst retail investors who own 36%, while hedge funds hold 28% (Simply Wall St.) -14.00%
Jun-28-23 02:16PM	Why Shares of Orchestra BioMed Holdings Jumped Wednesday (Motley Fool) +24.85%
Jun-26-23 08:00AM	Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes (GlobeNewswire) -9.81%
Jun-07-23 08:30AM	Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer (GlobeNewswire) -6.42%
Jun-01-23 08:00AM	Orchestra BioMed to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +8.93%
May-12-23 09:15AM	Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-11-23 05:39AM	3 Stocks That Already Doubled in 2023 and Could Keep Climbing (Motley Fool) +10.12%
Mar-27-23 06:05AM	Orchestra BioMed Holdings Full Year 2022 Earnings: US$14.60 loss per share (vs US$10.90 loss in FY 2021) (Simply Wall St.)
Mar-24-23 03:52PM	Why Shares of Orchestra BioMed Jumped This Week (Motley Fool)
Mar-07-23 08:00AM	Orchestra BioMed to Present at Upcoming Investor Conferences (GlobeNewswire) -6.77%
Feb-24-23 08:00AM	Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT and Virtue® SAB at CRT 2023 (GlobeNewswire)
Feb-07-23 08:00AM	Orchestra BioMed Strengthens Senior Leadership Team (GlobeNewswire)

Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded on May 25, 2020 and is headquartered in New Hope, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Taylor Andrew Lawrence	Chief Financial Officer	Dec 19 '24	Buy	4.83	1,000	4,830	344,960	Dec 20 08:30 AM
Hochman David P	See Remarks	Dec 18 '24	Buy	4.91	5,000	24,550	575,498	Dec 19 08:30 AM
Hochman David P	See Remarks	Sep 25 '24	Buy	4.75	7,500	35,630	335,002	Sep 26 08:15 AM
Hochman David P	See Remarks	Sep 24 '24	Buy	4.91	2,500	12,275	570,498	Sep 26 08:15 AM
Sherman Darren	See Remarks	Sep 09 '24	Sale	5.48	6,804	37,286	772,691	Sep 10 07:45 PM
Sherman Darren	See Remarks	Sep 10 '24	Sale	5.31	6,904	36,660	765,787	Sep 10 07:45 PM
Fain Eric S	Director	Sep 06 '24	Sale	5.64	2,000	11,280	44,810	Sep 10 07:43 PM
Fain Eric S	Director	Sep 09 '24	Sale	5.43	1,800	9,774	43,010	Sep 10 07:43 PM
Fain Eric S	Director	Sep 10 '24	Sale	5.34	1,800	9,612	41,210	Sep 10 07:43 PM
Fain Eric S	Director	Sep 10 '24	Proposed Sale	5.34	1,800	9,620		Sep 10 05:11 PM
Sherman Darren	Officer	Sep 10 '24	Proposed Sale	5.31	6,904	36,647		Sep 10 04:41 PM
Fain Eric S	Director	Sep 09 '24	Proposed Sale	5.43	1,800	9,774		Sep 09 04:48 PM
Sherman Darren	Officer	Sep 09 '24	Proposed Sale	5.48	6,804	37,319		Sep 09 03:48 PM
Sherman Darren	See Remarks	Sep 04 '24	Sale	6.10	6,837	41,706	793,275	Sep 06 07:31 PM
Sherman Darren	See Remarks	Sep 05 '24	Sale	5.85	6,961	40,722	786,314	Sep 06 07:31 PM
Sherman Darren	See Remarks	Sep 06 '24	Sale	5.65	6,819	38,527	779,495	Sep 06 07:31 PM
Sherman Darren	Officer	Sep 06 '24	Proposed Sale	5.65	6,819	38,513		Sep 06 04:20 PM
Fain Eric S	Director	Sep 06 '24	Proposed Sale	5.64	2,000	11,279		Sep 06 04:13 PM
Sherman Darren	Officer	Sep 05 '24	Proposed Sale	5.85	6,961	40,709		Sep 05 04:30 PM
Sherman Darren	Officer	Sep 04 '24	Proposed Sale	6.10	6,837	41,702		Sep 04 04:10 PM
Hochman David P	See Remarks	Aug 14 '24	Buy	5.84	2,500	14,600	567,998	Aug 15 05:30 PM
Hochman David P	See Remarks	Jun 25 '24	Buy	6.95	1,000	6,950	333,502	Jun 26 04:15 PM
Little William Reed	See Remarks	May 30 '24	Buy	7.00	4,000	28,000	307,859	Jun 03 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OBIO

Orchestra BioMed Holdings Inc

Upgrade your FINVIZ experience